The pathophysiology of immunoporosis: innovative therapeutic targets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pathophysiology of immunoporosis: innovative therapeutic targets
Authors
Keywords
-
Journal
INFLAMMATION RESEARCH
Volume 70, Issue 8, Pages 859-875
Publisher
Springer Science and Business Media LLC
Online
2021-07-17
DOI
10.1007/s00011-021-01484-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Mediterranean Diet in Osteoporosis Prevention: An Insight in a Peri- and Post-Menopausal Population
- (2021) Sara Quattrini et al. Nutrients
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
- (2020) Dolores Shoback et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand
- (2020) Chatlert Pongchaiyakul et al. JOURNAL OF MEDICAL ECONOMICS
- Betulinic Acid Inhibits RANKL-Induced Osteoclastogenesis via Attenuating Akt, NF-κB, and PLCγ2-Ca2+ Signaling and Prevents Inflammatory Bone Loss
- (2020) Da Hye Jeong et al. JOURNAL OF NATURAL PRODUCTS
- Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
- (2020) Jiyong Wei et al. Frontiers in Pharmacology
- Inhibitory effect of oolonghomobisflavan B on osteoclastogenesis by suppressing p38 MAPK activation
- (2020) Soomin Lim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Mediterranean diet and menopausal health: An EMAS position statement
- (2020) Antonio Cano et al. MATURITAS
- BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signaling
- (2019) Rui Zuo et al. Stem Cell Research & Therapy
- Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL)
- (2019) Konstantinos Tilkeridis et al. MEDICAL SCIENCE MONITOR
- Romosozumab: First Global Approval
- (2019) Anthony Markham DRUGS
- The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
- (2019) Aleksandra Musiał-Wysocka et al. CELL TRANSPLANTATION
- PTH 1-34 Loaded Thiolated Chitosan Nanoparticles for Osteoporosis: Oral Bioavailability and Anabolic Effect on Primary Osteoblast Cells (Journal of Biomedical Nanotechnology, Vol. 10(1), pp. 166–178 (2014))
- (2019) Deepa Narayanan et al. Journal of Biomedical Nanotechnology
- New Frontiers in Osteoporosis Therapy
- (2019) Cheng Cheng et al. Annual Review of Medicine
- Poloxamer Hydrogels for Biomedical Applications
- (2019) Eleonora Russo et al. Pharmaceutics
- Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties
- (2018) Ricchard Hallan Felix Viegas de Souza et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
- (2018) Qin Shi et al. International Journal of Nanomedicine
- Preparation of micrometric powders of parathyroid hormone (PTH1–34)-loaded chitosan oligosaccharide by supercritical fluid assisted atomization
- (2018) Dong-Xiao Hong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effects of RANKL Knockdown by Virus-like Particle-Mediated RNAi in a Rat Model of Osteoporosis
- (2018) Daniel B. Hoffmann et al. Molecular Therapy-Nucleic Acids
- Immunoporosis: Immunology of Osteoporosis—Role of T Cells
- (2018) Rupesh K. Srivastava et al. Frontiers in Immunology
- Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions
- (2018) Karim El Kholy et al. Frontiers in Immunology
- Screening, prevention and management of osteoporosis among Canadian adults
- (2018) Siobhan O’Donnell et al. Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice
- Romosozumab for the treatment of osteoporosis
- (2017) Leonardo Bandeira et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Mechanisms of Regulation of the Chemokine-Receptor Network
- (2017) Martin Stone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems
- (2017) Kazuo Okamoto et al. PHYSIOLOGICAL REVIEWS
- Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
- (2017) Pancras C. Wong et al. Science Translational Medicine
- Concise Review: MSC-Derived Exosomes for Cell-Free Therapy
- (2017) Donald G. Phinney et al. STEM CELLS
- Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α–Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis
- (2016) Hiroyuki Kanzaki et al. JOURNAL OF IMMUNOLOGY
- Bone Formation and the Wnt Signaling Pathway
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teriparatide for osteoporosis: importance of the full course
- (2016) R. Lindsay et al. OSTEOPOROSIS INTERNATIONAL
- Understanding the Regulatory Roles of Natural Killer T Cells in Rheumatoid Arthritis: T Helper Cell Differentiation Dependent or Independent?
- (2016) J. Chen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
- (2016) E Spanoudakis et al. Blood Cancer Journal
- Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis
- (2016) Jeffrey Kiernan et al. Stem Cells Translational Medicine
- Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis
- (2016) Bingdong Sui et al. Stem Cells Translational Medicine
- Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications
- (2015) S. D’Oronzo et al. CANCER TREATMENT REVIEWS
- The osteocyte plays multiple roles in bone remodeling and mineral homeostasis
- (2015) Huayue Chen et al. Medical Molecular Morphology
- MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
- (2014) L Kordelas et al. LEUKEMIA
- Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
- (2014) Matthew C. Walsh et al. Frontiers in Immunology
- Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1
- (2013) Min Zhu et al. FASEB JOURNAL
- In Vitro and in Vivo Evaluation of Osteoporosis Therapeutic Peptide PTH 1–34 Loaded PEGylated Chitosan Nanoparticles
- (2013) Deepa Narayanan et al. MOLECULAR PHARMACEUTICS
- CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance
- (2013) Adam Greenbaum et al. NATURE
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Osteoclasts: New Insights
- (2013) Feng Xu et al. Bone Research
- Immune Regulation of Osteoclast Function in Postmenopausal Osteoporosis: A Critical Interdisciplinary Perspective
- (2012) Renqing Zhao International Journal of Medical Sciences
- Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-α
- (2012) Diarmaid D Houlihan et al. Nature Protocols
- The Role of Diet in Osteoporosis Prevention and Management
- (2012) Silvina Levis et al. Current Osteoporosis Reports
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Osteoporosis and inflammation
- (2010) Paulo Gustavo Sampaio Lacativa et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation
- (2010) Ying Xiong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Novel Viral Vector Systems for Gene Therapy
- (2010) Daniel Stone Viruses-Basel
- Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair
- (2009) Matthew Schnoke et al. BONE
- Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis
- (2009) Nikolaus B Binder et al. NATURE MEDICINE
- CTLA-4 directly inhibits osteoclast formation
- (2008) R Axmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
- (2008) Ann E. Kearns et al. ENDOCRINE REVIEWS
- Osteoporosis in Men
- (2008) Sundeep Khosla et al. ENDOCRINE REVIEWS
- NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism
- (2008) Antonios O. Aliprantis et al. JOURNAL OF CLINICAL INVESTIGATION
- Application of Small Interfering RNA for Inhibition of Lipopolysaccharide-induced Osteoclast Formation and Cytokine Stimulation
- (2008) Farshid S. Fahid et al. JOURNAL OF ENDODONTICS
- Bone-protective Effects of Nonviral Gene Therapy With Folate–Chitosan DNA Nanoparticle Containing Interleukin-1 Receptor Antagonist Gene in Rats With Adjuvant-induced Arthritis
- (2008) Julio C Fernandes et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now